⚠ BETA β€” all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 16, 2026

NSE

Anupam Rasayan India LimitedANURAS

Nifty Smallcap 250

Anupam Rasayan India Limited is a leading manufacturer of organic and inorganic chemicals, serving various industries including pharmaceuticals, agrochemicals, and water treatment.

Key productsOrganic and inorganic chemicals
GeographyIndia (domestic market)
CompetitorsHindustan Salts Limited, Indian Fine Chemicals Ltd

AI-generated overview β€” verify before relying on it.

Net institutional flow

No institutional deals

Institutional buyers

0 in / 0 out

High-impact filings

0 Β· tilt Bullish

Next corporate action

β€”

Competitive landscape β€” the read

vs mapped peers
Institutional money is backing ACUTAAS hardest (+β‚Ή98.2 Cr net). ANURAS ranks #3 of 9 on flow (net buying +β‚Ή0 Cr). Filing momentum favours ANURAS (+1). News & social buzz is most positive on ACUTAAS.
#CompanyInst. flow β‚ΉCrDealsHi-impactFiling mom.BuzzNews
1ACUTAAS+β‚Ή98.2 Cr1β€”β€”+46
2AAVAS+β‚Ή79.7 Cr5β€”β€”β€”β€”
3ANURASThisβ€”β€”β€”+1β€”β€”
4AADHARHFCβ€”β€”β€”β€”β€”β€”
5AARTIIND+β‚Ή0 Cr4β€”β€”β€”β€”
6ACE+β‚Ή0 Cr2β€”β€”β€”β€”
7ACMESOLARβˆ’β‚Ή80.9 Cr1β€”β€”+26
8ABLBLβˆ’β‚Ή314.4 Cr29β€”β€”β€”β€”
9ABFRLβˆ’β‚Ή730.3 Cr13β€”+1β€”β€”

Ranked by net institutional flow (buys βˆ’ sells, β‚ΉCr). Filing momentum = bullish βˆ’ bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline β€” ANURAS day by day

Merged from deals, filings, corporate actions and news β€” newest first. Scope the deal/action portion with the period chips below.

Filings that matter

  • 2
    Press ReleaseNeutral

    a press release dated Jun 11, 2026, titled Anupam Rasayan India Limited becomes the first company in the world to commercialise ETFA (Ethyl trifluoroacetate) using flow chemistry"".

    Source PDF β†’
  • 5
    M&ABullish

    Draft Letter of Offer filed by the Manager to the Offer with SEBI yesterday, relating to the mandatory open offer by our Company to the public shareholders of Bliss GVS Pharma Limited

    Source PDF β†’
  • 2
    Shareholding DisclosureNeutral

    a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

    Source PDF β†’
  • 2
    Shareholding DisclosureNeutral

    a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

    Source PDF β†’
  • 2
    Shareholding DisclosureNeutral

    a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

    Source PDF β†’

Bulk & block deals

No bulk/block deals for ANURAS in this window.

News & chatter on ANURAS

RSS News

0

No recent news.

Google News RSS β€” links open the source.

The Dispatch

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.